Hypogonadism and erectile dysfunction as harbingers of systemic disease.

Document Type

Journal Article

Publication Date

4-1-2016

Journal

Translational Andrology and Urology

Volume

5

Issue

2

Inclusive Pages

195-200

DOI

10.21037/tau.2016.03.05

Abstract

Prescription sales of Testosterone and erectile aids such as phosphodiesterase-5 inhibitors are at an all-time high, underscoring the importance of hypogonadism (HG) and erectile dysfunction (ED) to men's health. The effect of these debilitating conditions has a major impact on the quality of men's lives. Some risk factors for HG or ED including aging, obesity, smoking, and a sedentary lifestyle. Notably, these are the same risk factors for several other medical co-morbidities that contribute to significant morbidity and mortality in men. HG and ED often co-exist with cardiovascular disease, diabetes, and osteoporosis. This review will explore these three co-morbidities that overlap with HG and ED, and will provide a review of their relationship with each other.

Comments

This is a free PMC article. Click the link for full text access.

Open Access

1

Link to Full Text

Share

COinS